November 2023 in “Scientific Papers Journal VETERINARY SERIES” Platelet-rich plasma can boost embryo production and implantation in mammals.
27 citations
,
May 2019 in “Jo'jig gonghag gwa jaesaeng uihag/Tissue engineering and regenerative medicine” The best method for urethral reconstruction is using hypoxia-preconditioned stem cells with autologous cells on a vascularized synthetic scaffold.
January 2023 in “International journal of sciences” Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.
5 citations
,
December 2018 in “Journal of Cosmetic Dermatology” PRP treatment improves hair count, density, and reduces hair loss in AGA patients.
November 2023 in “Regenerative Biomaterials” The new adhesive seals wounds quickly, works well in wet conditions, and helps with healing.
10 citations
,
July 2023 in “Pharmaceutics” Activating PKM2 and Wnt/β-catenin signaling speeds up wound healing.
May 2021 in “Benha Journal of Applied Sciences” Platelet-rich plasma injections significantly improved acne scars on treated areas of the face.
December 2025 in “International Journal of Innovative Technologies in Social Science” Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.
PRP injections can effectively and safely treat alopecia areata.
2 citations
,
November 2025 in “Journal of the American Academy of Dermatology” Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.
May 2024 in “Open Access Journal of Disease and Global Health” PRP injections improve skin and hair quality, boost self-esteem, and are safe and satisfying for patients.
3 citations
,
October 2025 in “Cancer” PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.
3 citations
,
November 2024 in “Clinical Research” Deuruxolitinib is FDA-approved for treating severe alopecia areata.
1 citations
,
January 2015 in “Sexual Medicine Reviews” Current treatments for recurrent ischemic priapism are not well-defined and need more research.
January 2026 in “OSF Preprints (OSF Preprints)” A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” November 2025 in “Zenodo (CERN European Organization for Nuclear Research)”
Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.
1 citations
,
January 2023 in “SAGE open medical case reports” A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.
April 2023 in “The Egyptian Journal of Hospital Medicine” Injecting platelet-rich plasma is a safe and effective way to improve different types of post-burn scars.
June 2020 in “Journal of Investigative Dermatology” FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.
4 citations
,
December 2019 in “Skin appendage disorders” Using Platelet-Rich Plasma injections for male-pattern baldness didn't significantly improve hair growth.
June 2025 in “Revista Foco” JAK inhibitors effectively treat severe alopecia areata with manageable side effects.
January 2017 in “Journal of cosmetology & trichology” Polydioxanone threads can effectively reduce hair loss and increase hair re-growth in patients with androgenetic alopecia, providing a quick and relatively painless treatment option.
22 citations
,
January 2018 in “European urology focus” New drugs and combination therapies are improving treatment for lower urinary tract symptoms.
3 citations
,
February 2023 in “International Journal of Molecular Sciences” Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.
May 2023 in “The Journal of Urology”
April 2025 in “Journal of Cosmetic and Laser Therapy” Microneedle delivery of platelet-rich plasma may be slightly better for hair regrowth than intradermal injection.
December 2015 in “PLOS ONE”